Cargando…

Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival?

Immunotherapy has considerably increased the number of anticancer agents in many tumor types including metastatic colorectal cancer (mCRC). Anti-PD-1 (programmed death 1) and cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) immune checkpoint inhibitors (ICI) have been shown to benefit the mCRC p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damilakis, Emmanouil, Mavroudis, Dimitrios, Sfakianaki, Maria, Souglakos, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225960/ https://www.ncbi.nlm.nih.gov/pubmed/32268531 http://dx.doi.org/10.3390/cancers12040889

Ejemplares similares

Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment
por: Koulouridi, Asimina, et al.
Publicado: (2021)

The Prognostic Value of the Detection of Microbial Translocation in the Blood of Colorectal Cancer Patients
por: Messaritakis, Ippokratis, et al.
Publicado: (2020)

Minuscule particles could hold key to invisible universes
por: Johnston, Ian
Publicado: (2006)

BRAFV600E Mutation Analysis in Patients with Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice: Correlations with Clinical Characteristics, and Its Impact on Patients’ Outcome
por: Saridaki, Zacharenia, et al.
Publicado: (2013)

PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer
por: Sfakianaki, Maria, et al.
Publicado: (2020)

Unraveling the Role of Molecular Profiling in Predicting Treatment Response in Stage III Colorectal Cancer Patients: Insights from the IDEA International Study
por: Messaritakis, Ippokratis, et al.
Publicado: (2023)

Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer
por: Messaritakis, Ippokratis, et al.
Publicado: (2018)

Deadly MERS virus could hold the key to its own cure
Publicado: (2014)

Primordial black holes could hold the key to dark matter mysteries
por: Waldrop, M. Mitchell
Publicado: (2022)

Evaluation of Microsatellite Instability Molecular Analysis versus Immuno-Histochemical Interpretation in Malignant Neoplasms with Different Localizations
por: Sfakianaki, Maria, et al.
Publicado: (2023)

Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies
por: Koulouris, Andreas, et al.
Publicado: (2021)

Investigation of Microbial Translocation, TLR and VDR Gene Polymorphisms, and Recurrence Risk in Stage III Colorectal Cancer Patients
por: Messaritakis, Ippokratis, et al.
Publicado: (2022)

The Role of Vitamin D Receptor Gene Polymorphisms in Colorectal Cancer Risk
por: Messaritakis, Ippokratis, et al.
Publicado: (2020)

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
por: Koulouridi, Asimina, et al.
Publicado: (2022)

Immunological combination treatment holds the key to improving survival in pancreatic cancer
por: Sodergren, M. H., et al.
Publicado: (2020)

Evaluation of the Role of Circulating Tumor Cells and Microsatellite Instability Status in Predicting Outcome of Advanced CRC Patients
por: Messaritakis, Ippokratis, et al.
Publicado: (2020)

Pancreatic Alpha Cells Hold the Key to Survival
por: Wali, Jibran A., et al.
Publicado: (2015)

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer
por: Papadaki, C, et al.
Publicado: (2014)

A Case Presentation of a Patient with Microsatellite Instability and BRAF Mutant Metastatic Colon Cancer and Bibliography Update
por: Thomopoulou, K., et al.
Publicado: (2019)

New policies to consolidate the journal’s hold on its latest position
por: Martelletti, Paolo
Publicado: (2008)

KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer
por: Kalikaki, Aristea, et al.
Publicado: (2014)

BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome
por: Saridaki, Z, et al.
Publicado: (2010)

Latest developments in MUC1 immunotherapy
por: Taylor-Papadimitriou, Joyce, et al.
Publicado: (2018)

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2(nd) Line Cetuximab-Based Therapy of Colorectal Cancer Patients
por: Saridaki, Zacharenia, et al.
Publicado: (2011)

Predictive Value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC Genes in Patients with Small Cell Lung Cancer (SCLC) Who Received First Line Therapy with Cisplatin and Etoposide
por: Karachaliou, Niki, et al.
Publicado: (2013)

Latest evidence on immunotherapy for cholangiocarcinoma
por: Guo, Xurui, et al.
Publicado: (2020)

Potential Positive Effects of COVID-19 on Cancer Care: A Window of Opportunity
por: Damilakis, Emmanouil
Publicado: (2022)

Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
por: Papadaki, Chara, et al.
Publicado: (2020)

The Place of Targeted Agents in the Treatment of Elderly Patients with Metastatic Colorectal Cancer
por: Matikas, Alexios, et al.
Publicado: (2015)

Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer
por: Sfakianaki, Maria, et al.
Publicado: (2019)

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
por: Papadaki, Maria A., et al.
Publicado: (2021)

Dark matter holds the key to universe
Publicado: (2009)

Dark matter holds the key to the universe
Publicado: (2009)

Replication studies hold the key to generalization
Publicado: (2022)

Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal Cancer
por: Koulouridi, Asimina, et al.
Publicado: (2020)

Advances in cancer immunotherapy 2019 – latest trends
por: Kruger, Stephan, et al.
Publicado: (2019)

Immunotherapy regimens for metastatic colorectal carcinomas
por: Bashir, Babar, et al.
Publicado: (2017)

Combinatorial Immunotherapies for Metastatic Colorectal Cancer
por: Janssen, Eline, et al.
Publicado: (2020)

Perspectives on Immunotherapy of Metastatic Colorectal Cancer
por: Dai, Yongjiu, et al.
Publicado: (2021)

Breath-holding could improve visualization of the internal jugular veins by ultrasound guidance in obese patients with trauma
por: Chen, Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dobl533jub0hbs7huu90dg6lnu